Intra-articular injection of platelet-rich plasma (PRP) has been established as a suitable treatment for knee osteoarthritis. Here, we present a double-blind randomized controlled clinical trial, conducted in a public Hospital of the Spanish National Health Care System, to evaluate the efficacy of injecting autologous PRP versus hyaluronic acid (HA) in knee osteoarthritis. PRP was manufactured in Malaga's Regional Blood Center (Spain). Patients that met the eligibility criteria were randomized into a PRP group or a HA group. Pain and functional improvements were assessed pre- and post-treatment (three and six months follow-up) using the Visual Analogue Scale (VAS); the Knee and Osteoarthritis Outcome System (KOOS) scale and the European Quality of Life scale (EUROQOL). Both groups presented pain reduction at six months. The VAS scores for the PRP group improved by at least 50
作者:Elvira, Monta?ez-Heredia;Sofia, Irízar;Pedro J, Huertas;Esperanza, Otero;Marta, Del Valle;Isidro, Prat;Macarena S, Díaz-Gallardo;Macarena, Perán;Juan A, Marchal;María Del Carmen, Hernandez-Lamas
来源:International journal of molecular sciences 2016 年 17卷 7期